1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874U |
Drug Screen (9 Panel), Urine |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541SP |
LSD Screen, Serum/Plasma |
2541U |
LSD Screen, Urine |
2584SP |
Methylenedioxyamphetamine, Serum/Plasma |
2584U |
Methylenedioxyamphetamine, Urine |
2585SP |
Methylenedioxymethamphetamine and Metabolite, Serum/Plasma |
2585U |
Methylenedioxymethamphetamine and Metabolite, Urine |
2679SP |
Mescaline, Serum/Plasma |
2679U |
Mescaline, Urine |
2680SP |
Mescaline Screen, Serum/Plasma |
2680U |
Mescaline Screen, Urine |
3532SP |
Phencyclidine Screen, Serum/Plasma |
3532U |
Phencyclidine Screen, Urine |
3957SP |
Procyclidine, Serum/Plasma |
3957U |
Procyclidine, Urine |
4029SP |
Psilocybin as Psilocin (Qualitative), Serum/Plasma |
4029U |
Psilocybin as Psilocin (Qualitative), Urine |
8031U |
Child Drug Exposure Screen, Urine |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8052SP |
Postmortem, Expanded, Serum/Plasma (Forensic) |
8052U |
Postmortem, Expanded, Urine (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8062U |
Postmortem, Expanded w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8091SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8091U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
8096SP |
Drugs of Abuse Screen (10 Panel), Serum/Plasma |
8096U |
Drugs of Abuse Screen (11 Panel), Urine |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8101SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8101U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8171U |
DUID/DRE Panel, Urine (Forensic) |
8758SP |
Hallucinogens Screen, Serum/Plasma |
8758U |
Hallucinogens Screen, Urine |
8761SP |
Phencyclidine, Serum/Plasma |
8761U |
Phencyclidine, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9293U |
Methylenedioxymethamphetamine and Metabolite Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |